Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Directed Radioligand Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Directed Radioligand Therapy

Published:2023-06-08 Issue:8 Volume:64 Page:1272-1278
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Hartrampf Philipp E.,Mihatsch Patrick W.,Seitz Anna Katharina,Solnes Lilja B.,Rowe Steven P.,Pomper Martin G.,Kübler Hubert,Bley Thorsten A.,Buck Andreas K.,Werner Rudolf A.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference45 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

4. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

5. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP